[HTML][HTML] Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

S Hu, X Su, G Fan - Diabetology & Metabolic Syndrome, 2023 - Springer
Objectives To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). Materials and methods PubMed, Science …

Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis.

S Hu, X Su, G Fan - Diabetology & Metabolic Syndrome, 2023 - europepmc.org
Objectives To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). Materials and methods PubMed, Science …

Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

S Hu, X Su, G Fan - Diabetology & Metabolic Syndrome, 2023 - search.proquest.com
Objectives To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). Materials and methods PubMed, Science …

[HTML][HTML] Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

S Hu, X Su, G Fan - Diabetology & Metabolic Syndrome, 2023 - ncbi.nlm.nih.gov
Objectives To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). Materials and methods PubMed, Science …

[HTML][HTML] Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

S Hu, X Su, G Fan - Diabetology & Metabolic …, 2023 - dmsjournal.biomedcentral.com
To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). PubMed, Science Direct, Cochrane …

Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

S Hu, X Su, G Fan - Diabetology & metabolic syndrome, 2023 - pubmed.ncbi.nlm.nih.gov
Objectives To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). Materials and methods PubMed, Science …

Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis.

S Hu, X Su, G Fan - Diabetology & Metabolic Syndrome, 2023 - search.ebscohost.com
Objectives: To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). Materials and methods: PubMed …

[PDF][PDF] Efficacy and tolerability of the Subcutaneous Semaglutide for type 2 Diabetes patients: an updated systematic review and meta-analysis

S Hu, X Su, G Fan - 2023 - dmsjournal.biomedcentral.com
Objectives To update and assess the efficacy and tolerability of once weekly subcutaneous
semaglutide in patients with type 2 diabetes (T2D). Materials and methods PubMed, Science …